| Authors: |
Vatzia E; The Pirbright Institute, Pirbright, UK., Paudyal B; The Pirbright Institute, Pirbright, UK., Dema B; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Carr BV; The Pirbright Institute, Pirbright, UK., Sedaghat-Rostami E; The Pirbright Institute, Pirbright, UK., Gubbins S; The Pirbright Institute, Pirbright, UK., Sharma B; The Pirbright Institute, Pirbright, UK., Moorhouse E; The Pirbright Institute, Pirbright, UK., Morris S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ulaszewska M; Nuffield Department of Medicine, University of Oxford, Oxford, UK., MacLoughlin R; Aerogen Ltd., Galway, Ireland., Salguero FJ; United Kingdom Health Security Agency, UKHSA-Porton Down, Salisbury, UK., Gilbert SC; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tchilian E; The Pirbright Institute, Pirbright, UK. elma.tchilian@pirbright.ac.uk. |